Medtech & Pharma Platform annual event keeps growing

    Press release, 25 October 2018

    The 5th anniversary of the international Medtech & Pharma Platform (MPP) annual event took place in Basel on 16-17 October 2018. With 270 participants coming from 14 countries and a balance between representatives from pharma and medtech sectors, the annual event proved once again to be a great success.

    The sessions of the 2018 MPP annual conference focused on “Global perspectives and trends at the intersection of pharma and medtech”, with presentations from renowned speakers on changing regulatory frameworks, digital health, innovative technologies, combined products development, transparency and management of patient data. Keynote speeches on major innovations in the two industries were given by Michael Doherty of Foundation Medicine and Charles Bridges from Actelion. In addition, Dr. Lukas Engelberger, Member of the Executive Council and Head of the Public Health Department of the Canton of Basel-City, welcomed the participants of the MPP 2018.

    In her opening speech, Mrs. Fürst-Ladani, President of the MPP association and CEO of SFL Regulatory Affairs & Scientific Communication, highlighted the recent publication of a White Paper on the EU regulatory and policy framework for combined products, that will serve as basis for dialogue with the European institutions, competent authorities and other stakeholders.

    The exhibition and 1-on-1 meetings

    In parallel with the program, 30 exhibitors showcased their technologies and services in the exhibition hall. Numerous stimulating discussions and the foundations for future collaborations were facilitated with a partnering tool that allowed attendees to directly contact and arrange 1-on-1 meetings during the conference breaks and designated networking sessions with other participants. Over 330 of these 1-on-1 partnering meetings complimented the spontaneous discussions that took place throughout the two days, highlighting the great networking value of the event.

    The Medtech & Pharma Platform (MPP) association

    The MPP, founded in 2017, is an international industry association focusing specifically on combined products at the EU level. The MPP industry association has emerged from the annual event that celebrated its 5th anniversary this year.

    With the goal to enhance the synergies between pharmaceutical and medtech companies, the association strives to improve access to innovative products for patients, by advocating on behalf of companies to reduce time to market for drugs, devices and combinations thereof. In order to achieve such goals, the MPP association formed a Working Group to proactively engage and communicate with EU institutions that shape the future policies for combined products.

    Save the date for next year’s MPP annual event, which will take place on 24 – 25 October 2019 in Basel.

    Medtech & Pharma Platform annual event celebrates its 5th anniversary in Basel

    Press release, Basel, 16 October 2018

    The Medtech & Pharma Platform (MPP) association is proud to announce the 5th anniversary of the MPP annual event, entitled “Global perspectives and trends at the intersection of pharma and medtech”. The event is taking place in Basel, Switzerland, on 16 - 17 October 2018.

    The MPP annual event, organized by the Medtech & Pharma Platform international industry association, is the leading conference in the sector of combined products, bringing together key stake­holders from medtech and pharmaceutical companies with the aim to encourage cross-sectoral collaboration, foster innovation and enhance synergies.

    Keynote speakers Michael Doherty of Foundation Medicine and Charles Bridges of Actelion will open the conference
    with insights into innovations at the intersection of pharma and medtech. Their presentations will be followed by a panel discussion featuring Matthew May of the European Patients’ Forum, who will bring the patients’ perspective on these innovative products.

    Over the two days, six sessions will focus on current topics relating to pharmaceuticals, medical devices, in-vitro diagnostics and combined products. Internationally acknowledged experts will discuss regulatory trends, innovative technologies, combined products development, digital health, and management of patient data.

    Ms Fürst-Ladani, President of the MPP association and CEO of SFL Regulatory Affairs & Scientific Communication commented: “We are proud to celebrate the 5th anniversary of the MPP annual event with an engaging program that gives attendees the opportunity to exchange knowledge and connect with international industry and regulatory experts. I am excited about the large number of senior professionals from international pharmaceutical and medtech companies attending the event this year”.

    In addition to the program, table top exhibitions and 1-on-1 partnering meetings will take place during the conference breaks, to facilitate networking and business partnerships among participants.

    The next year’s Medtech & Pharma Platform annual event will take place on 24-25 October 2019 in Basel.

    The Medtech & Pharma Platform (MPP) welcomes new members and extends its board of directors

    On July 2nd 2018, the General Assembly of the Medtech & Pharma Platform association (MPP) welcomed the new members MSD Merck Sharp & Dohme, Novartis and Ypsomed. With its enlarged membership base, the MPP will reinforce its efforts to reduce time to market for combined products, improve patient access and expand cooperation between medtech and pharma industries.

     

    New Board members

    Beside the existing board members, Shayesteh Fürst-Ladani (SFL) and Peter Biedermann (Swiss Medtech), the General Assembly elected Manfred Mäder (Novartis) and Stephan Affolter (Ypsomed) into the MPP board. Novartis and Ypsomed are leading companies in the development and marketing of combined products and have been active in MPP since its foundation. Shayesteh Fürst-Ladani, co-founder of MPP, was confirmed in her role as MPP president.

    Launch of the working group on combined products

    The MPP working group on combined products will utilize its expertise in key regulatory aspects and political decision-making processes to promote a balanced regulatory framework that facilitates market access for safe, innovative and well-established combined products.

    A combined product can be a medicinal product used in combination with any device, in vitro diagnostic or e-/m-health product, whether as an integral product or not.

    About the Medtech & Pharma Platform

    The Medtech & Pharma Platform is an industry association with the aim of enhancing the synergies between medtech and pharmaceutical industries by establishing a forum to exchange knowledge and collaborate in technology and regulatory areas, as well as to promote product development and innovation

    Beyond the international annual conference that had its inaugural meeting in 2014, the association aims to further strengthen advocacy work for companies to reduce time to market for drugs, devices and combinations thereof; improve access to innovative products; better match patients' needs and expand business opportunities for both industries.

    Combination products: highly innovative, but complex

    Download here the report of the MPP 2017 from Swiss Medtech

    Kombinierte Produkte: hochinnovativ, aber complex

    Successful 4th Medtech & Pharma Platform 2017

     

    The 4th international Medtech & Pharma Platform (MPP) conference, held in Basel and co-organized by SFL and Swiss Medtech, attracted delegates and speakers from 11 countries, representing pharma and medtech companies, regulatory agencies, academic organizations, government institutions and service companies.

    “Medical products and technologies for cutting-edge solutions”

    In line with the 2017 conference theme, the six sessions of the two-day program focused on hot topics related to medical devices, in-vitro diagnostics and combination products. Internationally acknowledged speakers discussed regulatory trends, innovative technologies, the role of design, connectivity in relation to health data, and accessibility of medical products in emerging markets.

    Fostering cross-sector contacts and cooperation

    Numerous stimulating discussions with table top exhibitors from different sectors, and during the highly rated 1-on-1 partnering meetings, allowed participants to exchange views on innovative technologies and facilitated the creation of lasting connections. The balance of delegates from medtech and pharma companies complemented the cross-sectoral character of the conference fittingly.

    The MPP association to engage in European policy work

    In her closing speech, Ms. Fürst-Ladani, CEO of SFL, highlighted the future directions of MPP and invited companies active in the field of combined products to become members of the MPP association. In the coming months, the MPP will be setting up working groups concerning the new medical devices and in vitro diagnostics regulations, with focus on European policy work. The group discussions aim to ensure that the interests of key stakeholders and MPP members are conveyed in the soon to be published delegated and implementing acts

    Save the date for the 5th anniversary of the MPP event on 16 – 17 October 2018, to be hosted in Basel.

    4th Annual Medtech & Pharma Platform Event “Medical products and technologies for cutting-edge solutions”

     

    Press release, Basel, 26 October 2017

    We are pleased to announce the 4th annual meeting of Medtech & Pharma Platform, entitled “Medical products and technologies for cutting-edge solutions”. The event is taking place in Basel, Switzerland, on 26 - 27 October, 2017.

    The Medtech & Pharma Platform annual meeting is the leading conference in the sector, bringing together key stakeholders from medtech and pharmaceutical industries with the aim to encourage cross-sectoral collaboration, foster innovation and strengthen synergies.

    Ms. Fürst-Ladani, President of the Medtech & Pharma Platform Program Committee and CEO of SFL Regulatory Affairs & Scientific Communication GmbH (SFL), will give the opening remarks followed by the keynote speech on “Medical device of tomorrow”. The six sessions, embeded in a two-day program, focus on hot topics related to medical devices, in-vitro diagnostics and combination products. Prominent speakers will discuss about regulatory trends, innovative technologies, the role of design, connectivity in relation to health data, and accessibility of medical products in emerging markets. In addition, table top exhibitions and one-on-one partnering meetings will take place during the conference to facilitate networking and knowledge exchange.

    “We have an outstanding line-up of speakers this year who will address some of the hot topics in the development of combination products”, commented Peter Biedermann, the Managing Director of Swiss Medtech.

    Ms. Fürst-Ladani agrees. “This year’s event offers an excellent opportunity for attendees to connect with international industry and regulatory experts experienced in providing solutions for combination product development,” she commented. “We are excited about the high level of interest and seniority of professionals from international medtech and pharma companies who are attending the conference.”

    The next year’s Medtech & Pharma Platform annual event will take place on 16-17 October 2018 in Basel.

     

    For further information:

    Shayesteh Fürst-Ladani, President of the association Medtech & Pharma Platform, +41 61 361 94 43
    office@medtech-pharma.com, http://www.medtech-pharma.com/

     

    Medtech & Pharma Platform

    c/o SFL Regulatory Affairs & Scientific Communication GmbH

    Margarethenstrasse 47, CH-4053 Basel, Switzerland

    --

    About SFL Regulatory Affairs & Scientific Communication
    SFL Regulatory Affairs & Scientific Communication GmbH (SFL) is a premium consultancy specialized in life sciences and co-organizer of Medtech & Pharma Platform annual meeting. SFL’s highly skilled team has in-depth expertise for medicines, medical devices, diagnostics and combination products and provides personalized and integrated solutions from the bench to approval and reimbursement within one consultancy. SFL’s expertise covers Regulatory Affairs, Public Affairs, Medical Affairs, Pharmacovigilance, Legal Advice, Quality Assurance, Pricing and Reimbursement.

    About Swiss Medtech
    Swiss Medtech is the largest Medtech Association in Switzerland, aiming to improve innovation for the medical technology industry and co-organizer of Medtech & Pharma Platform annual meeting. Swiss Medtech supports the interconnectivity between all stakeholders in the medical technology industry and provides fundamentals for a better understanding of the industry, its opportunities and challenges.

    Medtech & Pharma Platform: establishment as an association strengthens activities and facilitates collaboration across pharma and medtech industries

     

    Press release, Basel, 22 February 2017

    In February 2017, the Swiss medtech industry organization, Medical Cluster, and the premium consulting company SFL founded the Medtech & Pharma Platform association. In doing so, the two founding members are building on the previous conferences’ success and strengthen their activities to foster cooperation between the medtech and pharma industries.

    By establishing a forum to exchange knowledge and collaborate in technology and regulatory areas, the aim of the new association is to capitalize on the synergies between medtech and pharmaceutical industries and to promote product development and innovation.

    The foundation of an association helps the Medtech & Pharma Platform to extend its activities beyond the annual conference which had its first meeting in 2014. Among other things, the founding members aim to strengthen advocacy work for companies to reduce time to market for drugs, devices and combinations thereof, improve access to innovative products, better match patients' needs and expand business opportunities for both industries.

    For further information:

    Shayesteh Fürst-Ladani, President of the association Medtech & Pharma Platform, +41 61 361 94 43
    office@medtech-pharma.com, http://www.medtech-pharma.com/

     

    Medtech & Pharma Platform

    c/o SFL Regulatory Affairs & Scientific Communication GmbH

    Margarethenstrasse 47, CH-4053 Basel, Switzerland

    --

    Medical Cluster is the Swiss Medtech Association which aims to improve innovation for medical technology industry in Switzerland. Medical Cluster supports the interconnectivity between all stakeholders in the medical technology industry and provide fundamentals for a better understanding of the industry, its opportunities and challenges. This summer, Medical Cluster will merge with FASMED to form SWISS MEDTECH – the largest Medtech Association of Switzerland.

    SFL Regulatory Affairs & Scientific Communication (SFL) is a premium consultancy specialized in life sciences. SFL’s highly skilled team has in-depth expertise for medicines, medical devices, diagnostics and combination products and provide personalized and integrated solutions from the bench to approval and reimbursement within one consultancy. SFL team expertise covers Regulatory Affairs, Public Affairs, Medical Affairs, Legal, Compliance, Pharmacovigilance, Quality Assurance, and Reimbursement.

     

    The full press release can be downloaded using the link below:

     Download